High BMI at time of diagnosis has no effect on clinical outcomes for HER2-positive breast cancer
Dion Smyth Lecturer-practitioner, Cancer and palliative care, Birmingham City University
In contrast with previous findings, a retrospective cohort study carried out in Italy has found no negative effect of body mass index (BMI) at the time of diagnosis on clinical outcomes for patients with HER2-positive metastatic breast cancer.
Cancer Nursing Practice. 17, 2,12-12. doi: 10.7748/cnp.17.2.12.s10
Published in print: 08 March 2018